In β-actin Knockouts, Epigenetic Reprogramming and RDNA Transcription Inactivation Lead to Growth and Proliferation Defects
Overview
Authors
Affiliations
Actin and nuclear myosin 1 (NM1) are regulators of transcription and chromatin organization. Using a genome-wide approach, we report here that β-actin binds intergenic and genic regions across the mammalian genome, associated with both protein-coding and rRNA genes. Within the rDNA, the distribution of β-actin correlated with NM1 and the other subunits of the B-WICH complex, WSTF and SNF2h. In β-actin(-/-) mouse embryonic fibroblasts (MEFs), we found that rRNA synthesis levels decreased concomitantly with drops in RNA polymerase I (Pol I) and NM1 occupancies across the rRNA gene. Reintroduction of wild-type β-actin, in contrast to mutated forms with polymerization defects, efficiently rescued rRNA synthesis underscoring the direct role for a polymerization-competent form of β-actin in Pol I transcription. The rRNA synthesis defects in the β-actin(-/-) MEFs are a consequence of epigenetic reprogramming with up-regulation of the repressive mark H3K4me1 (monomethylation of lys4 on histone H3) and enhanced chromatin compaction at promoter-proximal enhancer (T0 sequence), which disturb binding of the transcription factor TTF1. We propose a novel genome-wide mechanism where the polymerase-associated β-actin synergizes with NM1 to coordinate permissive chromatin with Pol I transcription, cell growth, and proliferation.-Almuzzaini, B., Sarshad, A. A. , Rahmanto, A. S., Hansson, M. L., Von Euler, A., Sangfelt, O., Visa, N., Farrants, A.-K. Ö., Percipalle, P. In β-actin knockouts, epigenetic reprogramming and rDNA transcription inactivation lead to growth and proliferation defects.
Biological functions and clinic significance of SAF‑A (Review).
Zhang D, Li L, Li M, Cao X Biomed Rep. 2024; 20(6):88.
PMID: 38665420 PMC: 11040223. DOI: 10.3892/br.2024.1776.
Prostaglandins limit nuclear actin to control nucleolar function during oogenesis.
Talbot D, Vormezeele B, Kimble G, Wineland D, Kelpsch D, Giedt M Front Cell Dev Biol. 2023; 11:1072456.
PMID: 36875757 PMC: 9981675. DOI: 10.3389/fcell.2023.1072456.
Baron F, Zhang M, Archer N, Bellows E, Knight H, Welham S RNA. 2023; 29(6):777-789.
PMID: 36810234 PMC: 10187669. DOI: 10.1261/rna.079615.123.
Cobb A, De Silva S, Hayward R, Sek K, Ulferts S, Grosse R Cell Death Dis. 2022; 13(12):1042.
PMID: 36522328 PMC: 9755150. DOI: 10.1038/s41419-022-05491-4.
Mahmood S, Hosny El Said N, Percipalle P Results Probl Cell Differ. 2022; 70:607-624.
PMID: 36348124 DOI: 10.1007/978-3-031-06573-6_22.